NCT02448576
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Not yet recruiting
Not Applicable
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: Female
Age: 18 Years to 65 Years (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: 
Exclusions: Patients with central nervous system (CNS) or leptomeningeal metastases
https://ClinicalTrials.gov/show/NCT02448576